The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity

Due to the increase in the number of infliximab products, the need for global harmonization of the bioactivity of this monoclonal antibody was recognized by the World Health Organization (WHO). In response, the National Institute for Biological Standards and Control (NIBSC) developed the first inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, Clive, Dougall, Thomas, Bird, Chris, Rigsby, Peter, Behr-Gross, Marie-Emmanuelle, Wadhwa, Meenu, study, participants of the
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343779/
https://www.ncbi.nlm.nih.gov/pubmed/30395763
http://dx.doi.org/10.1080/19420862.2018.1532766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343779/
https://www.ncbi.nlm.nih.gov/pubmed/30395763
http://dx.doi.org/10.1080/19420862.2018.1532766

Ejemplares similares